1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: UARK 2003-26, NCT00090493
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 to 60 Sponsor: Other Protocol IDs: 6889, CNPq 577582/2008-9, NCT01584115
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: 12-000153, NCI-2012-01548, NCT01697527
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 16 and over Sponsor: NCI, Other Protocol IDs: MCC-15400, NCI-P-7997, CA209-006/007, 10-15526-99-01, 7997, NCT01176461
|
|
5.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LUD2012-004, NCT01810016
|